The World Cup Has a Ticket Problem & The First Ever Reverse-Aging Drug

June 10, 2026

AI Summary

5 min read

The World Cup is one day from kickoff with a glut of unsold tickets, the FDA has approved the first new sunscreen ingredient in decades, and a longevity startup has injected the first patient in a clinical trial aimed at reversing aging. These are the three dominant stories in this episode of Morning Brew Daily, which also covers the completion of Barcelona’s Sagrada Familia after 144 years, Anthropic’s launch of a heavily guarded new AI model, and the naming of the crew for Artemis III.

FIFA’s Ticket Gamble Backfires

With the World Cup set to begin, FIFA faces an embarrassing problem: empty seats. A Financial Times analysis found that nearly 180,000 tickets remain available on official resale platforms. Ticket prices on the portal have slid 20% over the past month, and once the 26% transaction fee is factored in, most resales are now likely to come at a loss. Even for the U.S. opener against Paraguay in Los Angeles, 4,400 tickets were still available for resale at a median price over $800.

Continue reading the full summary in the app — free to try.

Read Full Summary →

Free • No credit card required

Listen to Audio Summary Open in App

Never miss an episode of Morning Brew Daily

Get every new episode summarized in your inbox — free, ~5 minutes to read.

No spam. Unsubscribe anytime.

What you'll learn

1 (00:51) **World Cup Ticket Glut & European Tourist Vibes** - Hosts discuss the contrast between viral European tourist excitement in the US South and FIFA's ticket pricing crisis.
2 (07:25) **First FDA-Approved Human Trial for Reverse-Aging Drug** - Life Biosciences begins a clinical trial to turn old cells into less old cells, targeting glaucoma.
3 (11:39) **Sagrada Familia Completed After 144 Years** - Pope Leo blesses the completion of the world's tallest church, inflaming debates about overtourism in Barcelona.
4 (17:28) **FDA Approves First New Sunscreen Ingredient in Decades** - BemoTrinzinol (BEMT) is approved, offering better UVA protection and no white residue.
5 (21:49) **Anthropic Launches Censored 'Mythos' Model as Claude Fable 5** - The powerful model is released with guardrails that block it from answering questions on sensitive topics like cybersecurity and biology.
6 (24:14) **NASA Names Crew for Artemis III** - The four-person crew will test crucial docking systems with lunar landers built by SpaceX and Blue Origin.
7 (25:53) **Suggestion Box: 82-and-0 Game & Concert Earplugs** - Hosts share weekly recommendations.

+ Full timestamped outline available in the app

Show Notes

#864: Neal and Toby talk about how the most expensive World Cup ever for fans… isn’t bringing in any fans. Plus, the first-ever reverse-aging drug was just injected into a human & Barcelona’s Sagrada Família Nears Completion. Finally, the U.S. has approved its first new sunscreen ingredient in nearly 30 years.

To learn more visit https://www.sage.com/morningbrew

Subscribe to Morning Brew Daily for more of the news you need to start your day. Share the show with a friend, and leave us a review on your favorite podcast app.

Listen to Morning Brew Daily Here:⁠ ⁠⁠https://www.swap.fm/l/mbd-note⁠⁠⁠

Watch Morning Brew Daily Here:⁠ ⁠⁠https://www.youtube.com/@MorningBrewDailyShow⁠

This is a paid advertisement. Today's episode of the Morning Brew Daily Show is brought to you by Sage — a trusted global provider and leader in accounting, financial, HR, and payroll technology for small and mid-sized businesses. The following commentary reflects general information about Sage and its products. Specific features, capabilities, and availability may vary by product, region, and customer requirements. To find out more, visit sage.com/morningbrew.

Learn more about your ad choices. Visit megaphone.fm/adchoices